Skip to content

Hold Alembic Pharma; target of Rs 625: ICICI Direct

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 625 in its research report dated November 14, 2022.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish